Abstract: Objective To investigate the neuroprotective effects of edaravone (Eda) on cobalt chloride (CoCl 2 )-induced oxidative stress and apoptosis in cultured PC12 cells as well as the underlying mechanisms. Methods PC12 cells impaired by CoCl 2 were used as the cell model of hypoxia. MTT (methyl thiazolyl tetrazolium) was used to assay the viability of the PC12 cells exposed to Eda with gradient concentrations; Hochest 33258 stain assay was used to analyze the apoptosis ratio of the PC12 cells; Bcl-2 and Bax protein levels in PC12 cells were examined by western blotting. ROS level, the mitochondrial transmembrane potential and caspase-3 activity in each group were detected by spectrofluorometer. Results CoCl 2 treatment caused the loss of cell viability in PC12 cells, which was associated with the elevation of apoptotic rate, the formation of ROS and the disruption of mitochondrial transmembrane potential. CoCl 2 also significantly induced the upregulation of Bax/Bcl-2 ratio and the activation of caspase-3. In contrast, Eda significantly reversed these phenotypes, with its maximum protective effect at 0.1 μmol/L. Conclusion These results indicated that Eda could protect PC12 cells from CoCl 2 -induced cytotoxicity, and this protection might be ascribed to its anti-oxidative and anti-apoptotic activities.
Introduction
It has been identified that apoptosis may be involved in neuronal diseases relevant to hypoxia [1] . Hypoxic/ischemic condition has long been recognized as an important mediator or modulator of apoptosis in neuronal cells because this condition is accompanied by the production of reactive oxygen species (ROS) which can attack nucleic acids, proteins and membrane phospholipids [2, 3] . The distinct mechanisms that execute apoptosis through various apoptotic stimuli, are ultimately classified into the mitochondria-dependent pathway (intrinsic pathway) and the death receptor-dependent pathway (extrinsic pathway) [4] . The mitochondria-dependent apoptotic pathway is stimulated under hypoxic/ischemia conditions [5] . These stimuli induce generation of ROS, loss of mitochondrial transmembrane potential (Δψm), release of cytochrome c from the impaired mitochondria to cytosol. The released cytochrome c forms a complex with Apaf-1 in the presence of dATP, which recruits and activates caspase-9.
Activated caspase-9 induces the activation of caspase-3, which subsequently contributes to apoptotic cell death [6, 7] .
Several reports indicated that cobalt chloride (CoCl 2 ) could mimic the hypoxic/ischemic conditions including the production of ROS in various cultured cells [8] [9] [10] . PC12 is a cell line derived from rat pheochromocytoma and has been widely used as an in vitro model for investigating neuronal apoptosis, oxygen sensor mechanism, and neuronal differentiation [11] . Therefore, we used CoCl 2 -treated PC12 cells as a model to study the neuronal cell response to hypoxia.
Edaravone (Eda) is kind of free-radical scavenger that has been evaluated as a neuroprotective compound which inhibits the increase of hydroxyl radical and superoxide anion level in several models of cerebral ischemia [12, 13] . Based on the fact that CoCl 2 induces a hypoxic/ischemic condition, this study was designed to investigate in molecular level the neuroprotective effects of Eda on pathways involved in CoCl 2 -induced apoptosis.
Materials and methods

Materials Eda was purchased from Mitsubishi Chemical
Industries (Japan 
Measurement of caspase-3 activity
Statistical analysis
Data were presented as mean ± SD.
Statistical significance was determined by one-way ANOVA followed by Tukey's post hoc test. P < 0.05 was considered statistically significant. Whereas the Eda treatment at a concentration from 0.001 to 10 μmol/L prevented the viability loss (Fig. 1C) .
Results
Eda inhibited CoCl
After the incubation with both Eda (0.1 μmol/L) and CoCl 2 (150 μmol/L), the cell viability increased to 64.7±5.2%.
The results in Fig. 1 indicated that Eda exhibited neuroprotective effects on CoCl 2 -induced cytotoxicity in PC12 cells in a dose-dependent manner, with its optimal concentration at 0.1 μmol/L. and at 0.1μmol/L, Eda showed a maximum inhibition (Fig. 4) . which was a sign of apoptosis inhibition (Fig. 5 ). 
Eda rescued CoCl
Eda attenuated the CoCl 2 induced increase of Bax to
Bcl-2 ratio
Eda inhibited caspase-3 activity in PC12 cells
Discussion
Hypoxia-induced cell death is a major concern in various clinical fields such as ischemic disease, organ transplantation, and other diseases. with mitochondria-mediated pathway [9] . The main mechanism for apoptosis appeared to be mitochondria-mediated pathway, which usually accompanied with loss of the Δψm followed by cytochrome c release from the mitochondria into the cytosol, resulting in the activation of caspase-9 and caspase-3.
Also, there occurred significant upregulation of pro-apoptotic protein Bax and downregulation of anti-apoptotic protein Bcl-2 in the presence of CoCl 2 , which then might result in activation of mitochondria-mediated apoptosis.
Some reports showed Eda could protect neural system against ischemia or hypoxia challenge. Using a rat model of transient middle cerebral artery occlusion, researchers concluded that daily treatment with Eda helped reduce cortical infarction volume [14] . Eda also salvaged the boundary zone of infarct by scavenging reactive oxygen species, especially in the neurons during permanent focal cerebral ischemia [15] .
In addition, Eda not only had antioxidant roles, but also protected cells from apoptosis [16, 17] . However, little information is available on antioxidant Eda in regulating the Bcl-2/Bax apoptotic pathway via mitochondria after CoCl 2 injury at cellular level.
In present study, we first observed the effects of and mitochondrial dysfunction [9, 18] . The production of ROS can lead to cell injury through cell membrane lipid destruction and DNA cleavage [19, 20] , thus plays a critical role in leading to final apoptosis. Recent investigations indicated that mitochondria played a prominent role in transduction and amplification of the apoptotic response. Eda has been shown to afford its neuroprotection by its antioxidant effects [21, 22] , which is further confirmed by our data that Eda is highly Consequently, some other mechanisms could also be pertinent in the Eda protective mechanism. Bcl-2 family plays a key role in the mitochondrial apoptotic pathway [23] . In the present study, Eda decreased the ratio of Bax to Bcl-2, by blocking the CoCl 2 -induced downregulation of Bcl-2. These results demonstrate that Eda inhibits CoCl 2 -induced apoptosis through the regulation of the Bcl-2 family. Furthermore, Eda attenuated the CoCl 2 -induced increase in caspase-3 activity.
From our own observations, a decrease in caspase-3 activity correlates well with a decrease in the Bax/Bcl-2 ratio, as proapoptotic Bax is thought to be upstream of the caspase in the mitochondria-mediated apoptotic death pathway [23] , suggesting that the mechanisms by which Eda inhibits CoCl 2 -triggered activation of caspase-3 might include both its antioxidative activity and its regulatory function in Bcl-2 family.
These results indicate that the neuroprotective effects of Eda may result from the inactivation of caspase cascade associated with mitochondria pathway by modulating Bcl-2 family on CoCl 2 -mediated apoptosis.
In this study, we demonstrated that Eda possessed a significant neuroprotective role against CoCl 2 -induced apoptosis in PC12 cells. Eda ameliorated CoCl 2 -induced ROS production, attenuated the mitochondrial transmembrane potential loss, downregulated the Bax/Bcl-2 ratio, and also prevented the activation of caspase-3. These findings support the theory that cytoprotection mediated by Eda is due, in part, to inhibition of the oxidative stress resulting from the mitochondrial apoptotic pathway.
